ID: ALA2385934

Max Phase: Preclinical

Molecular Formula: C23H22N2O4

Molecular Weight: 390.44

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1OCCNCCN1C(=O)c2cccc3cccc(c23)C1=O

Standard InChI:  InChI=1S/C23H22N2O4/c1-28-19-10-2-3-11-20(19)29-15-13-24-12-14-25-22(26)17-8-4-6-16-7-5-9-18(21(16)17)23(25)27/h2-11,24H,12-15H2,1H3

Standard InChI Key:  SHIILLPPZNZCME-UHFFFAOYSA-N

Associated Targets(Human)

Beta-N-acetyl-D-hexosaminidase-A/B 71 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 390.44Molecular Weight (Monoisotopic): 390.1580AlogP: 3.11#Rotatable Bonds: 8
Polar Surface Area: 67.87Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.79CX LogP: 3.03CX LogD: 1.63
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.47Np Likeness Score: -0.69

References

1. Guo P, Chen Q, Liu T, Xu L, Yang Q, Qian X..  (2013)  Development of Unsymmetrical Dyads As Potent Noncarbohydrate-Based Inhibitors against Human β-N-Acetyl-d-hexosaminidase.,  (6): [PMID:24900704] [10.1021/ml300475m]

Source